Cargando…
Novel Treatments for Patients With Relapsed/Refractory Multiple Myeloma
Therapeutic options for patients with multiple myeloma have multiplied in the past decade. However, multiple myeloma remains an incurable disease, and relapsed/refractory myeloma is characterized by genetic and cytogenetic alterations that drive resistance and result in progressively shorter duratio...
Autores principales: | Rodriguez, Cesar, Catamero, Donna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184840/ https://www.ncbi.nlm.nih.gov/pubmed/37197721 http://dx.doi.org/10.6004/jadpro.2023.14.3.14 |
Ejemplares similares
-
Integrating Best Practices to Improve Outcomes in Relapsed/Refractory Multiple Myeloma
por: Pierre, Amy E., et al.
Publicado: (2020) -
Updates on Therapeutic Advancements in Relapsed or Refractory Multiple Myeloma: Highlights From SOHO 2020
Publicado: (2021) -
BCMA-Directed CAR T Cells in Relapsed Refractory Multiple Myeloma: Highlights From SOHO 2021
Publicado: (2022) -
Treatment of relapsed and refractory multiple myeloma
por: Lee, Ji Hyun, et al.
Publicado: (2020) -
Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma
por: Fostier, Karel, et al.
Publicado: (2012)